Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 4(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03834363Phase 4Completed

Morphine or Fentanyl for Refractory Dyspnea in COPD

Role: collaborator

NCT02301286Phase 3Active Not Recruiting

A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Role: collaborator

NCT04014634Phase 4Completed

GON-injection for a Sooner and Better Treatment of Cluster Headache

Role: collaborator

NCT04225312Phase 4Unknown

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis

Role: collaborator

NCT03212352Phase 4Terminated

Comparing Two Medical Treatments for Early Pregnancy Failure.

Role: collaborator

NCT03361514Not ApplicableCompleted

Discontinuation of Antidepressant Medication in Primary Care.

Role: collaborator

NCT00893438Not ApplicableCompleted

Efficacy of Web-based Cognitive Behavioural Treatment for Adolescents With Chronic Fatigue Syndrome

Role: collaborator

All 7 trials loaded